CA
NZ
UK
AU
IND
US
Rumble Inc. (NASDAQ:RUM)disclosed a significant GPU services commitment from Tether, the largest digital asset company and creator of the widely adopted dollar stablecoin. Tether’s initial pledge covers up to USD 150 mn of GPU services over a two-year period, dependent on the closing of …
Jabil Inc. (NYSE:JBL), a global engineering, supply chain, and manufacturing solutions company, has announced an expanded collaboration with Inno, a metal parts manufacturer and subsidiary of Shanghai Xinpeng Industry Co. (XP). The two companies will jointly invest in a 15,000-square-meter, two-building facility in Rayong, …
Innate Pharma SA (NASDAQ:IPHA) announced that the U.S. Food and Drug Administration (FDA) has completed its review of the confirmatory Phase 3 protocol for lacutamab in cutaneous T-cell lymphomas (CTCL). The FDA had no further comments, allowing the trial to proceed.
Viomi Technology Co., Ltd. (NASDAQ:VIOT), a technology company specializing in home water solutions in China, announced its unaudited financial results for the six months ended June 30, 2025.
Kyivstar Group Ltd. (NASDAQ:KYIV), Ukraine’s leading digital operator, released selected unaudited financial and operational results for the third quarter ending September 30, 2025. Total revenue climbed 20.9% YoY to UAH 12.3 bn (USD 297 mn), reflecting the Group’s pricing policies and growth in consumer …
e.l.f. Beauty (NYSE:ELF)has officially launched its products at ULTA Beauty locations throughout Mexico, following the brand’s initial market introduction in 2024. The launch represents a continuation of the partnership between e.l.f. and ULTA Beauty, offering customers nationwide access to e.l.f. Cosmetics and e.l.f. SKIN …
Organon (NYSE:OGN)reported findings from a sub-analysis of pooled data from the Phase 3 ADORING 1 and ADORING 2 trials at the 2025 American College of Allergy, Asthma & Immunology Annual Scientific Meeting. The analysis assessed VTAMA® (tapinarof) cream, 1%, in children aged 2-17 with …
Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, released results from the pivotal Phase 3 CORALreef HeFH trial at the American Heart Association Scientific Sessions 2025. The study assessed enlicitide decanoate, an investigational once-daily oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, …
Edwards Lifesciences (NYSE:EW)has announced its founding sponsorship of the American Heart Association’s Heart Valve Initiative, a nationwide effort to enhance care and outcomes for approximately 28 million people worldwide living with heart valve disease. In the U.S., valve disease contributes to over 60,000 deaths …
VEON Ltd. (NASDAQ:VEON)reported a 7.5% year-on-year rise in revenue to USD 1,115 mn for the third quarter ended September 30, 2025. EBITDA grew 19.7% YoY to USD 524 mn, supported by telecom and infrastructure operations along with higher digital contributions. The EBITDA margin expanded …
Please wait processing your request...